Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0.

American journal of hematology·2026
Same author

Engineering single-chain variable fragments to identify pathogenic antibodies in heparin-induced thrombocytopenia.

Blood·2026
Same author

Red blood cell transfusion thresholds in acute leukemia: Current practice and physician perspectives from a national survey.

Transfusion·2026
Same author

Vein-to-vein data: what predicts platelet response?

Blood advances·2026
Same author

Spontaneous Heparin-Induced Thrombocytopenia after Total Hip Arthroplasty.

The New England journal of medicine·2026
Same author

Guideline on the emergency management of critical bleeding in patients with immune thrombocytopenia.

Blood advances·2026

Related Experiment Video

Updated: Apr 16, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.4K

The platelet serotonin-release assay.

Theodore E Warkentin1,2, Donald M Arnold2, Ishac Nazi2

  • 1Department of Pathology and Molecular Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.

American Journal of Hematology
|March 18, 2015
PubMed
Summary

The platelet serotonin-release assay (SRA) is highly effective for diagnosing heparin-induced thrombocytopenia (HIT). This test identifies specific antibodies that activate platelets, confirming HIT with high accuracy.

More Related Videos

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

8.3K
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

3.9K

Related Experiment Videos

Last Updated: Apr 16, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.4K
A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

8.3K
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

3.9K

Area of Science:

  • Hematology
  • Immunology
  • Clinical Diagnostics

Background:

  • Heparin-induced thrombocytopenia (HIT) is a severe prothrombotic disorder.
  • HIT is caused by antibodies against platelet factor 4 (PF4)/heparin complexes.
  • Accurate laboratory diagnosis of HIT is crucial for patient management.

Purpose of the Study:

  • To evaluate the diagnostic utility of the platelet serotonin-release assay (SRA) for HIT.
  • To compare the specificity of SRA with enzyme-immunoassay (EIA).
  • To explore the significance of heparin-independent platelet activation in severe HIT.

Main Methods:

  • The study focuses on the performance characteristics of the SRA.
  • It discusses the use of EIA as a screening or adjunct test for SRA.
  • Analysis of SRA results in relation to clinical context and antibody profiles.

Main Results:

  • A positive SRA is highly diagnostic for HIT in the correct clinical setting.
  • SRA demonstrates high sensitivity and specificity, with a small percentage of indeterminate results.
  • Combining SRA with EIA enhances diagnostic specificity by reducing false positives.

Conclusions:

  • The SRA is a valuable and specific diagnostic tool for HIT.
  • Heparin-independent platelet activation detected by SRA indicates severe HIT.
  • SRA provides critical information for managing HIT patients and assessing thrombosis risk.